Abstract:Mitochondrial dysfunction plays a pivotal role in necroapoptotic cell death and in the development of acute kidney injury (AKI). Evidence suggests that glycogen synthase kinase (GSK) 3 beta resides at the nexus of multiple signaling pathways implicated in the regulation of rnitochondrial permeability transition (MPT). In cultured renal tubular epithelial cells, a discrete pool of GSK3 beta was detected in mitochondria. Coimmunoprecipitation assay confirmed that GSK3 beta physically interacts with cyclophilin F and voltage-dependent anion channel (VDAC), key MPT regulators that possess multiple GSK3 beta phosphorylation consensus motifs, suggesting that GSK3 beta has a direct control of MPT. Upon a strong burst of reactive oxygen species elicited by the pro-oxidant herbicide paraquat, the activity of the redox-sensitive GSK3 beta was drastically enhanced. This was accompanied by augmented phosphorylation of cyclophilin F and VDAC, associated with MPT and cell death. Inhibition of GSK3 beta by either the selective inhibitor 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) or forced expression of a kinase-dead mutant obliterated paraquat-induced phosphorylation of cyclophilin F and VDAC, prevented MPT, and improved cellular viability. Conversely, ectopic expression of a constitutively active GSK3 beta amplified the effect of paraquat on cyclophilin F and VDAC phosphorylation and sensitized cells to paraquat-induced MPT and death. In vivo, paraquat injection elicited marked oxidant stress in the kidney and resulted in acute kidney dysfunction and massive tubular apoptosis and necrosis. Consistent with in vitro findings, the activity of GSK3 beta was augmented in the kidney after paraquat injury, associated with increased phosphoiylation of cyclophilin F and VDAC and sensitized MPT. TDZD-8 blocked GSK3 beta activity in the kidney, intercepted cyclophilin F and VDAC phosphorylation, prevented MPT, attenuated tubular cell death, and ameliorated paraquat-induced AKI. Our data suggest that the redox-sensitive GSK3 beta regulates renal tubular injury in AKI by controlling the activity of MPT regulators. (C) 2013 Elsevier Inc. All rights reserved.

The Key Roles of GSK-3β in Regulating Mitochondrial Activity

Glycogen synthase kinase-3 (GSK3): Regulation, actions and diseases.

Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease

Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases

Pharmacological Targeting of GSK3β Confers Protection Against Podocytopathy and Proteinuria by Desensitizing Mitochondrial Permeability Transition

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

GSK-3 in Neurodegenerative Diseases

Studies of glycogen synthase kinase-3 inhibitors

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer's Disease

Targeting glycogen synthase kinase-3 β for Alzheimer's disease: Recent advances and future Prospects

Targeting Glycogen Synthase Kinase-3Β for Alzheimer's Disease: Recent Advances and Future Prospects

Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases

The Role of Glycogen Synthase Kinase 3 Beta in Neurodegenerative Diseases

Redox-Sensitive Glycogen Synthase Kinase 3 Beta-Directed Control Of Mitochondrial Permeability Transition: Rheostatic Regulation Of Acute Kidney Injury

Biological Evaluation and Energetic Analyses of Novel GSK‐3β Inhibitors

Association of Glycogen Synthase Kinase-3Β with Parkinson’s Disease (Review)

GSK3 is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target

Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.

GSK-3beta, a therapeutic target for cardiomyocyte protection

GSK3: A potential target and pending issues for treatment of Alzheimer's disease

Microsecond Molecular Dynamics Simulations and Dynamic Network Analysis Provide Understanding of the Allosteric Inactivation of GSK3β Induced by the L343R Mutation